Pericapsular Nerve Group Block Chemical Neurolysis in Advanced Hip Osteoarthritis

NCT ID: NCT06087588

Last Updated: 2025-01-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-10-17

Study Completion Date

2025-01-14

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

PENG neurolysis in advanced osteoarthritis of the hip joint.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study aims to assess the safety and effectiveness of regional pain treatment methods and their impact on the quality of life of patients with advanced osteoarthritis of the hip joint.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Osteoarthritis Osteoarthritis, Hip

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Group 1 - PENG sham block Group 2 - PENG neurolysis 95% ethanol
Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Caregivers Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

sham PENG block

PENG block - 20ml 0,9% normal saline

Group Type ACTIVE_COMPARATOR

0.9%sodium chloride

Intervention Type DRUG

PENG sham block with 20ml 0,9% normal saline

PENG neurolysis

PENG neurolysis with 5ml 95% ethanol

Group Type ACTIVE_COMPARATOR

95% ethanol

Intervention Type DRUG

PENG neurolysis with 2.5ml of 95% ethanol

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

0.9%sodium chloride

PENG sham block with 20ml 0,9% normal saline

Intervention Type DRUG

95% ethanol

PENG neurolysis with 2.5ml of 95% ethanol

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Sham block neurolysis

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients of the Pain Treatment Clinic of the Transfiguration of Jesus Clinical Hospital of the Medical University of Poznań will be qualified for the study
* patients with coxarthrosis or gonarthrosis who failed to achieve satisfactory pain control (NRS\>3) despite the use of NSAIDs, Paracetamol, and co-analgetics
* Age of patients: from 18 to 110 years of age.
* Caucasian patients can give informed, complete, written consent.

Exclusion Criteria

* suspected or diagnosed opioid dependence syndrome
* active cancer
* dementia
Minimum Eligible Age

18 Years

Maximum Eligible Age

100 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Poznan University of Medical Sciences

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Katarzyna Wieczorowska-Tobis, Prof.dr hab

Role: STUDY_DIRECTOR

Poznań University of Medical Sciences

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Poznan University of Medical Sciences

Poznan, Poznań, Poland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Poland

References

Explore related publications, articles, or registry entries linked to this study.

Reysner M, Reysner T, Kowalski G, Mularski A, Daroszewski P, Wieczorowska-Tobis K. Chemical ablation of pericapsular nerve group with 95% ethanol for pain relief and quality of life in patients with hip osteoarthritis: a prospective, double-blinded, randomised, controlled trial. Br J Anaesth. 2025 Aug;135(2):382-389. doi: 10.1016/j.bja.2025.04.045. Epub 2025 Jun 6.

Reference Type DERIVED
PMID: 40480912 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

5/2023

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.